BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24777709)

  • 41. Success Rate of Probing for Congenital Nasolacrimal Duct Obstruction in Children.
    Valcheva KP; Murgova SV; Krivoshiiska EK
    Folia Med (Plovdiv); 2019 Mar; 61(1):97-103. PubMed ID: 31237856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Congenital Nasolacrimal Duct Obstruction: Comparison of Two Different Treatment Algorithms.
    Napier ML; Armstrong DJ; McLoone SF; McLoone EM
    J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):285-91. PubMed ID: 27486727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Late and very late initial probing for congenital nasolacrimal duct obstruction: what is the cause of failure?
    Kashkouli MB; Beigi B; Parvaresh MM; Kassaee A; Tabatabaee Z
    Br J Ophthalmol; 2003 Sep; 87(9):1151-3. PubMed ID: 12928286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcanalicular endoscopic primary dacryoplasty for congenital nasolacrimal duct obstruction.
    Matsumura N; Suzuki T; Goto S; Fujita T; Yamane S; Maruyama-Inoue M; Kadonosono K
    Eye (Lond); 2019 Jun; 33(6):1008-1013. PubMed ID: 30783256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spontaneous Resolution and Timing of Intervention in Congenital Nasolacrimal Duct Obstruction.
    Sathiamoorthi S; Frank RD; Mohney BG
    JAMA Ophthalmol; 2018 Nov; 136(11):1281-1286. PubMed ID: 30178001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the success rate between monocanalicular and bicanalicular intubations in incomplete complex congenital nasolacrimal duct obstruction.
    Eshraghi B; Jamshidian-Tehrani M; Mirmohammadsadeghi A
    Orbit; 2017 Aug; 36(4):215-217. PubMed ID: 28627964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Probing in Congenital Nasolacrimal Duct Obstruction in Children Older Than 2 Years.
    Une VL; Kulkarni SS; Nandedkar VS
    J Pediatr Ophthalmol Strabismus; 2019 May; 56(3):141-145. PubMed ID: 31116859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anisometropia and Amblyopia Outcomes in Early Versus Late Resolution of Congenital Nasolacrimal Duct Obstruction in Older Infants.
    Sims DT; Gillette TB; Lam JG; Liu D; Lee C; Ding L; Tarczy-Hornoch K; Cabrera MT
    Ophthalmic Plast Reconstr Surg; 2024 Jan-Feb 01; 40(1):39-42. PubMed ID: 38241617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Factors affected therapeutic results in treatment of children congenital nasolacrimal duct obstruction by Ritleng lacrimal intubation].
    Yu G; Hu M; Wu Q; Cao WH; Fan YW; Lin Q; Liu W
    Zhonghua Yan Ke Za Zhi; 2012 May; 48(5):423-7. PubMed ID: 22932332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tobramycin/dexamethasone eye drops as a better choice for lacrimal duct probing in persistent congenital nasolacrimal duct obstruction: A consort study.
    Xiang Q; Hu D; Gao X
    Medicine (Baltimore); 2019 Feb; 98(6):e14188. PubMed ID: 30732134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Case Series of Dacryoendoscopy in Childhood: A Diagnostic and Therapeutic Alternative for Complex Congenital Nasolacrimal Duct Obstruction Even in the First Year of Life.
    Heichel J; Struck HG; Fiorentzis M; Hammer T; Bredehorn-Mayr T
    Adv Ther; 2017 May; 34(5):1221-1232. PubMed ID: 28341931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of probing for children with congenital nasolacrimal duct obstruction: a retrospective study using fluorescein dye disappearance test and lacrimal sac echography.
    Steindler P; Mantovani E; Incorvaia C; Parmeggiani F
    Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):837-46. PubMed ID: 19107503
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome of late probing for congenital nasolacrimal duct obstruction in Singapore children.
    Yap EY; Yip CC
    Int Ophthalmol; 1997-1998; 21(6):331-4. PubMed ID: 9869342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcome of monocanalicular intubation for complex congenital nasolacrimal duct obstruction: the role of age.
    Eshraghi B; Ghadimi H; Karami S; Nikdel M
    Rom J Ophthalmol; 2022; 66(1):49-54. PubMed ID: 35531458
    [No Abstract]   [Full Text] [Related]  

  • 55. Management of congenital nasolacrimal duct obstruction--latin american study.
    Schellini SA; Ariki CT; Sousa RL; Weil D; Padovani CR
    Ophthalmic Plast Reconstr Surg; 2013; 29(5):389-92. PubMed ID: 23924988
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Success of balloon catheter dilatation as a primary or secondary procedure for congenital nasolacrimal duct obstruction.
    Tao S; Meyer DR; Simon JW; Zobal-Ratner J
    Ophthalmology; 2002 Nov; 109(11):2108-11. PubMed ID: 12414423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intraoperative prognostic factors for probing outcome in children with congenital nasolacrimal duct obstruction.
    Andalib D; Nabei R
    Eur J Ophthalmol; 2013; 23(3):329-32. PubMed ID: 23225091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monocanalicular silastic intubation for the initial correction of congenital nasolacrimal duct obstruction.
    Engel JM; Hichie-Schmidt C; Khammar A; Ostfeld BM; Vyas A; Ticho BH
    J AAPOS; 2007 Apr; 11(2):183-6. PubMed ID: 17307001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crigler Massage for Congenital Blockade of Nasolacrimal Duct.
    Durrani J
    J Coll Physicians Surg Pak; 2017 Mar; 27(3):145-148. PubMed ID: 28406772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of age on primary balloon dacryocystoplasty and probing success in congenital nasolacrimal duct obstruction.
    Dericioğlu V; Sevik MO; Saçu SS; Eraslan M; Çerman E
    Int Ophthalmol; 2022 Nov; 42(11):3547-3554. PubMed ID: 35598226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.